Laprise JF, Chesson HW, Markowitz LE, Drolet M, et al. Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States. Ann Intern Med 2025;178:1674-1675.
PMID: 41248506